Search results
From Self-sufficiency
- !Receptor <br/> (↑ = opens. ↓ = closes) <ref name=boron/> <br> <font size=1> On [ |rowspan=2| [[nitric oxide]] || ↑[[NO receptor]] on smooth muscle || ↑[[cyclic GMP|cGMP]] --> ↑[[protein kinase g|PKG]13 KB (1,665 words) - 21:28, 21 September 2010
- ...enin-Angiotensin System: Emphasis on Blockade of the Angiotensin II Type-1 Receptor ...(ARBs) can be used to prevent angiotensin II from acting on [[angiotensin receptor]]s.11 KB (1,520 words) - 12:30, 28 January 2012
- ...tp://www.nature.com/bjp/journal/v143/n4/full/0705974a.html "Selective GABA-receptor actions of amobarbital on thalamic neurons."] ''British Journal of Pharmaco ...t (military)|frontline]].<ref>[http://www.pbs.org/wgbh/amex/bulge/filmmore/pt.html Use of sodium amytal during WWII]</ref>9 KB (1,128 words) - 22:04, 21 September 2010
- ...month= November | year= 1975 | pages= 530–4 | volume= 18 | issue= (5 Pt 1) | pmid=1102231 | accessdate= 2008-02-22}}</ref><ref name="Phillips">{{ci ...ref> and there may be other modes of action such as through [[histamine H3 receptor]]s<ref name="Girard">{{cite journal | author= Girard P, Pansart Y, Coppé M9 KB (1,159 words) - 22:06, 21 September 2010
- ...ervous]] and [[immune system]]s of animals and that activate [[cannabinoid receptor]]s , and 3. '''synthetic cannabinoids''', a structurally diverse class of m {{Main|Cannabinoid receptor}}49 KB (6,487 words) - 22:06, 21 September 2010
- ...brain: isolation, structure elucidation, and interactions with the opiate receptor |journal=Proc Natl Acad Sci USA |volume=73 |issue=7 |pages=2515–9 |year=1 ...for the κ<sub>1</sub> opioid receptors. μ opioid receptors are the main receptor through which [[morphine]] acts. Classically, μ opioid receptors are presy18 KB (2,467 words) - 22:06, 21 September 2010
- ...elieve minor throat irritation. Menthol also acts as a weak [[kappa Opioid receptor]] [[agonist]]. [[pt:Mentol]]15 KB (2,008 words) - 22:07, 21 September 2010
- ...ub>1</sub>]] and [[CB2 receptor|CB<sub>2</sub>]] [[receptor_(biochemistry)|receptor]]s, with lower [[affinity_(pharmacology)|affinity]] in comparison to [[THC] [[pt:Canabinol]]3 KB (352 words) - 22:07, 21 September 2010
- | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0271-0749&volum ...affinity for [[Cannabinoid_receptor#CB1|CB<sub>1</sub>]] and [[Cannabinoid receptor#CB2|CB<sub>2</sub>]] receptors but acts as an indirect antagonist of cannab17 KB (2,198 words) - 22:07, 21 September 2010
- ...|CB<sub>1</sub>]] receptor, which is the most abundant [[G protein-coupled receptor]] in the [[brain]]. ...inoid receptor]] antagonist [[rimonabant]] (SR141716A) as well as [[opioid receptor]] antagonists (opioid blockers) [[naloxone]] and [[naloxonazine]].<ref name50 KB (6,686 words) - 22:09, 21 September 2010
- ...de Lamarck, J.B. 1785. ''Encyclopédie Méthodique de Botanique'', vol. 1, pt. 2. Paris, France, pp. 694-695</ref> Lamarck based his description of the n ...nabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function|journal = [[Pharmacology]]|volume = 83|issue = 4|pages = 217–22276 KB (10,798 words) - 22:10, 21 September 2010
- ...f the amyloid precursor protein | journal = J. Cell. Sci. | volume = 113 ( Pt 11) | issue = | pages = 1857–70 | year = 2000 | month = June | pmid = 108 ...comparisons to the signaling role of the surface [[transmembrane receptor|receptor]] protein [[Notch signaling|Notch]].<ref name="Selkoe">{{cite journal | aut36 KB (4,595 words) - 22:11, 21 September 2010
- || [[Dopamine receptor]]s at pathway terminations. ...gmental nuclei]] (''pontomesencephalotegmental complex'') || (mainly) [[M1 receptor]]s in:11 KB (1,374 words) - 22:11, 21 September 2010
- ...=|accessdate=}}</ref> Signal transduction starts with a signal to a receptor, and ends with a change in cell function. ...de the cell. The chemical signal binds to the outer portion of the receptor, changing its shape and conveying another signal inside the cell. So55 KB (7,677 words) - 22:12, 21 September 2010
- *Some [[transient receptor potential channel]]s: This group of channels, normally referred to simply a ...nion-permeable γ-aminobutyric acid-gated [[GABA receptor|GABA<sub>A</sub> receptor]].31 KB (4,177 words) - 22:12, 21 September 2010
- Loperamide is an [[opioid]]-receptor [[agonist]] and acts on the [[Mu Opioid receptor|μ-opioid receptors]] in the [[myenteric plexus]] of the large intestine; b [[pt:Loperamida]]7 KB (989 words) - 22:12, 21 September 2010
- ...antagonist|antagonist]] activity at the [[kappa opioid receptor|κ-opioid receptor]]. Buprenorphine [[hydrochloride]] was first marketed in the 1980s by Recki Suboxone contains buprenorphine as well as the [[opioid]] [[receptor antagonist|antagonist]] [[naloxone]] to deter the abuse of tablets by [[int59 KB (8,561 words) - 22:13, 21 September 2010
- ...8}}</ref> In addition, it is a synthetic strong agonist at the [[mu opioid receptor|μ-opioid]] receptors. Historically it has been used to treat [[breakthroug [[pt:Fentanil]]33 KB (4,684 words) - 21:01, 24 September 2010
- ...lly unlike [[morphine]] or [[heroin]], methadone also acts on the [[opioid receptor]]s and thus produces many of the same effects. Methadone is also used in ma ...receptor, but also has some affinity for the [[NMDA]] ionotropic glutamate receptor. It is metabolized by the enzymes [[CYP3A4]], [[CYP2B6]] and [[CYP2D6]], wi61 KB (8,865 words) - 22:13, 21 September 2010
- ...2receptorsimplications for models of schizophrenia](2002)</ref> Other NMDA receptor antagonists include [[ketamine]], [[tiletamine]], and [[dextromethorphan]]. In a similar manner, PCP and analogues also inhibit [[nicotinic acetylcholine receptor]] channels (nAChR). Some analogues have greater potency at nAChR than at NM21 KB (3,002 words) - 21:02, 24 September 2010
- ...potent [[Kappa Opioid receptor|κ-opioid]] and [[D2 receptor|D<sub>2</sub> receptor]] [[agonist]].<ref name="Zhang2005pabs" /><ref name="Seeman2009">[[#refSeem ...ain a [[Base (chemistry)|basic]] [[nitrogen]]), unlike most known [[opioid receptor]] [[ligand]]s.<ref name="Harding2006p107">[[#refHarding2006|Harding, Schmid133 KB (18,241 words) - 22:14, 21 September 2010
- As a narcotic, hydrocodone relieves [[pain]] by binding to [[opioid receptor]]s in the [[brain]] and [[spinal cord]]. It can be taken with or without f [[pt:Diidrocodeína]]30 KB (4,151 words) - 22:14, 21 September 2010
- ...ssociative]] [[hallucinogen]]. Its [[mechanism of action]] is as an [[NMDA receptor antagonist]], producing effects similar to those of the controlled substan ...7 | doi = 10.1097/ANA.0b013e31817f523f | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0898-4921&volum26 KB (3,444 words) - 22:15, 21 September 2010
- ...It has also been shown that Alfaxalone binds to a different region of this receptor than the benzodiazipines (2). Alfaxalone is metabolised rapidly in the live ...RL, et al. A single amino acid of the human gamma-aminobutyric acid type A receptor gamma 2 subunit determines benzodiazepine efficacy. J Biol Chem 1994;269:323 KB (405 words) - 21:00, 24 September 2010
- ...n]] [[protein dimer|dimer]] complex. The [[gene]] [[encoding]] an ethylene receptor has been cloned in ''[[Arabidopsis thaliana]]'' and then in [[tomato]]. Eth Ethylene hormone receptor action in Arabidopsis. Chang C, Stadler R. Bioessays. 2001 Jul;23(7):619-2732 KB (4,462 words) - 21:01, 24 September 2010
- Etomidate is an agonist at [[GABAA receptor|GABA<sub>A</sub>]] [[Receptor (biochemistry)|receptors]]<ref>Vanlersberghe C, Camu F. Etomidate and other [[pt:Etomidato]]10 KB (1,350 words) - 21:01, 24 September 2010
- ...Receptor antagonist|antagonist]] of N-methyl-d-aspartate receptors ([[NMDA receptor]]s). These receptors exacerbate the damage from [[oxygen deprivation]] and [[Category:NMDA receptor antagonists]]82 KB (11,842 words) - 21:02, 24 September 2010
- ...l analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. ''Journal of Medicinal Chemistry''. 2002 Jul 18;45(15):3210–21. PMID 121 [[pt:Propofol]]21 KB (2,875 words) - 21:03, 24 September 2010
- ...0s by Dr. [[Henri Laborit]] to use in studying the neurotransmitter [[GABA receptor|GABA]].<ref>{{cite journal | author = H. Laborit, J.M. Jouany, J. Gerald, F ...}</ref> and it is a weak agonist at the [[GABA receptor|GABA<sub>B</sub>]] receptor, which is [[inhibitory]].<ref name="mechanism" /> GHB is a naturally-occurr55 KB (7,839 words) - 21:04, 24 September 2010
- [[ca:Receptor superheterodí]] [[es:Receptor superheterodino]]31 KB (4,651 words) - 14:50, 10 December 2011